Merrimack Pharmaceuticals (MACK) Earnings Date, Estimates & Call Transcripts → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free MACK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 15) -$0.03 Missed By -$0.03 Get Merrimack Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for MACK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMACK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MACK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details MACK Earnings Date and InformationMerrimack Pharmaceuticals last announced its earnings results on May 15th, 2024. The biopharmaceutical company reported ($0.03) earnings per share (EPS) for the quarter. Merrimack Pharmaceuticals has generated $13.87 earnings per share over the last year ($13.87 diluted earnings per share) and currently has a price-to-earnings ratio of 1.1. Merrimack Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Merrimack Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/15/2024Q1 2024-($0.03)($0.03)($13.99)--3/7/2024Q4 2023-($0.01)($0.01)($0.01)--11/2/2023Q3 2023-($0.02)($0.02)($0.02)--8/3/2023Q2 2023-($0.03)($0.03)($0.03)--5/4/2023Q1 2023-($0.02)($0.02)($0.02)--3/9/2023Q4 2022-($0.03)($0.03)($0.03)-- Get the Latest News and Ratings for MACK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022-($0.03)($0.03)($0.03)--8/4/2022Q2 2022-($0.04)($0.04)($0.04)--5/5/2022Q1 2022-($0.04)($0.04)($0.07)--3/9/2022Q4 2021-($0.03)($0.03)($0.03)--11/4/2021Q3 2021-($0.04)($0.04)($0.04)--8/5/2021Q2 2021-($0.06)($0.06)($0.06)--5/6/2021Q1 2021-($0.05)($0.05)($0.05)--3/10/2021Q4 2020-($0.08)($0.08)($0.08)--11/5/2020Q3 2020-($0.08)($0.08)($0.08)--8/7/2020Q2 2020-($0.09)($0.09)($0.09)--5/7/2020Q1 2020-$0.02+$0.02$0.02--11/12/2019Q3 2019-($0.05)($0.05)($0.05)--7/17/2019Q2 2019-($0.71)($0.71)($0.71)-- Merrimack Pharmaceuticals Earnings - Frequently Asked Questions When is Merrimack Pharmaceuticals's earnings date? Merrimack Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on MACK's earnings history. How much profit does Merrimack Pharmaceuticals generate each year? Merrimack Pharmaceuticals (NASDAQ:MACK) has a recorded net income of -$1.18 million. MACK has generated $13.87 earnings per share over the last four quarters. What is Merrimack Pharmaceuticals's price-to-earnings ratio? Merrimack Pharmaceuticals (NASDAQ:MACK) has a trailing price-to-earnings ratio of 1.09. More Earnings Resources from MarketBeat Related Companies: Lexicon Pharmaceuticals Earnings Date Vanda Pharmaceuticals Earnings Date XOMA Earnings Date Agenus Earnings Date Emergent BioSolutions Earnings Date Codexis Earnings Date Achieve Life Sciences Earnings Date Rigel Pharmaceuticals Earnings Date Regulus Therapeutics Earnings Date Sangamo Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:MACK) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merrimack Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
